Fosun Pharma to Invest $17.6 Million in EOS Imaging of France

Fosun Pharma announced it will make a $17.6 million investment into EOS Imaging of France. EOS concentrates on the orthopedic imaging market, making 2D/3D imaging devices that limit dosing for patient safety along with imaging and surgical planning software. After the investment, Fosun will own 13% of EOS, and it will help EOS expand its sales in China, the company's third largest market after the EU and the US. Fosun will have a EOS board seat. More details....

Stock Symbols: (SH: 600196: HK: 02196) (P: EOSI)

Share this with colleagues:

Original Article: Fosun Pharma to Invest $17.6 Million in EOS Imaging of France

More From BioPortfolio on "Fosun Pharma to Invest $17.6 Million in EOS Imaging of France"